Status:
RECRUITING
The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
Lead Sponsor:
University Health Network, Toronto
Conditions:
Thyroid Nodule
Thyroid Cancer
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is: • What is the feasibility of RFA use for low-ris...
Detailed Description
This is a single center, prospective case series designed to assess the feasibility of RFA therapy (using an investigational RFA device) in a small cohort of participants at University Health Network ...
Eligibility Criteria
Inclusion
- 1\. Patients with:
- Nodule less than or equal to 2cm in size
- a. Specifically: Bethesda 5/6
- Their age is ≥18 years and ≤100 years
- Able to provide written consent
- Able to attend required follow-ups as per the protocol
Exclusion
- Patients \<18 years old
- Pregnant women
- Any concern for invasive or metastatic thyroid cancer
- Previously treated for thyroid cancer
Key Trial Info
Start Date :
April 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06929650
Start Date
April 20 2023
End Date
December 31 2025
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G2C4